Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Renal Cell Carcinoma

Expert Opinion / Guidelines · July 03, 2014

Metastatic Clear Cell Renal Cell Carcinoma: First-Line Treatment

Bradley Somer MD

 

 Save  Recommend
 Share

Additional Info

  1. Schmidinger M. Improving outcomes in metastatic clear cell renal cell carcinoma by sequencing therapy. Available at: http://meetinglibrary.asco.org/content/11400228-144. Accessed June 24, 2014.

  2. Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer, version 2.2014. J Natl Compr Canc Netw. 2014;12:175-182.

  3. Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii65-vii71.

  4. Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398-406.

  5. Rini BI, Cohen DP, Lu DR, et al. Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib. J Natn Cancer Inst. 2011;103:763-773.

  6. Felici A, Bria E, Tortora G, et al. Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR. Expert Rev Anticancer Ther. 2012;12:1545-1557.

  7. Heng YC, Xie W, Regan MM et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor- targeted agents: Results from a large, multicenter study. J Clin Onc 2009; 27: 5794-5799

Disclosure statements are available on the authors' profiles:

Bradley Somer MD

Further Reading

Recently Updated